According to the media outlet NEWS on the 29th, JTI Korea will launch a new product called "Mevius LBS Citro Wave 3mg," which promises a refreshing taste with dual capsules and a unique filter mouthpiece. At the same time, the new product "Mevius LBS Citro Wave 3mg" combines two different capsules to deliver a fresh and crisp flavor on top of a refreshing base.
The new product "Mevius LBS Citro Wave 3mg" has a refreshing and palate-pleasing taste when opening two different capsules, harmonizing with a cool taste profile. Its packaging design also shines brightly, using vibrant gold and fresh green colors, sensually expressing the product's unique and delicious flavor. Built on a foundation of mature smoking culture that considers social responsibility, this new product also incorporates JTI's two unique reduced-smoke technologies.
The LBS (Less Breath Smell) technology can effectively reduce the smell of smoke in the mouth, while the LSS (Less Smoke Smell) special technology can reduce the smell of smoke in the air.
A JTI Korea insider stated, "Given the positive response from consumers to recent LBS products, we have decided to launch 'Mevius LBS Citro Wave 3mg' with an ultimate fresh taste. We will also continue to introduce a variety of products with unique flavors to expand the selection for adult smokers."
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
